Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group
- Status
- WITHDRAWN
- Phase
- N/A
Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.
- Status
- TERMINATED
- Phase
- PHASE2
Retrospective Analysis of Lymphomas and Cancers Synchronous Occurrence in Picardy From 2007 to 2012
- Status
- WITHDRAWN
- Phase
- N/A
High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT
- Status
- COMPLETED
- Phase
- N/A
Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Study Evaluating the Incidence of Post Lumbar Puncture Headache With Atraumatic Needles in Hematology
- Status
- COMPLETED
- Phase
- NA
A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1
CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
- Status
- COMPLETED
- Phase
- N/A
Study Evaluating the Efficacy and Safety With CAR-T Immunotherapy for CD19 Positive Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2